| Austin's Grace Hospice, Llc 7800 Shoal Creek Blvd Ste 120w, Austin, TX, 78757 | |
| (512) 300-2100 |
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| Name | Austin's Grace Hospice, Llc |
|---|---|
| Location | 7800 Shoal Creek Blvd Ste 120w, Austin, Texas |
| Hospice ID | 671538 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 940 |
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| NPI Number | 1184650632 |
| Organization Name | Grace Hospice Of Austin, Llc |
| Address | 7800 Shoal Creek Blvd Austin, Texas, 78757 |
| Phone Number | (512)300-2100 |
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| NPI Number | 1275644353 |
| Organization Name | A-med Community Hospice-austin, Inc. |
| Address | 7800 Shoal Creek Blvd Austin, Texas, 78757 |
| Phone Number | (512)323-6500 |
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| NPI Number | 1760603591 |
| Organization Name | Nurses To Go, Inc. |
| Address | 7800 Shoal Creek Blvd Austin, Texas, 78757 |
| Phone Number | (512)323-6500 |
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 96.2 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 89.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 52.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 89.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 81.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 65.2 | 93.3 |
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| Home Health Aides | 2 |
| Counselors | 0.7 |
| Medical Social Workers | 1 |
| Registered Nurses | 1.75 |
| Total Employees | 5.45 |
|---|
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| Others | 0.8 |
| Total Volunteers | 0.8 |
|---|
News Archive
Grassroots knowledge from Indigenous people can help to map and monitor ecological changes and improve scientific studies, according to Rutgers-led research.
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
› Verified 3 days ago
| Hospice Austin Location: 4107 Spicewood Springs Rd Ste #100, Austin, Texas, 78759 Phone: (512) 300-2100 |
| Aseracare Hospice Location: 14205 Burnet Road Suite 470, Austin, Texas, 78728 Phone: (512) 300-2100 |
| Robinson Creek Home Health And Hospice Location: 609 Castle Ridge Road Suite #300, Austin, Texas, 78746 Phone: (512) 300-2100 |
| Gentiva Hospice Location: 3307 Northland Drive Suite 300, Austin, Texas, 78731 Phone: (512) 300-2100 |